Buprenorphine linked to reduced rate of adverse outcomes, including severe maternal morbidity, NICU admissions, and preterm births
Clinicians should provide or refer those at increased risk to counseling interventions during pregnancy, postpartum
Commercial administrative claims data show slight increase in annual prevalence from 2015 to 2020
Findings persist across various periods
No increase reported in psychotherapy claims during pregnancy; medication fills returned to prepregancy levels within one month after birth
Mothers with MS have higher incidence of any mental illness and of all mental illnesses except suicide
Increased risks seen for autism, intellectual disability, ADHD, among others
Rate of severe maternal morbidity 292.1 per 10,000 live births among those with OUD, with variation seen across states
SSRI-exposed children did not have increased risk of functional nausea and vomiting or functional abdominal pain disorders
IPV linked to delayed or no prenatal care, depression in pregnancy, cigarette smoking, substance use, low birth weight